Goldman Sachs’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-20,000
Closed -$1.91M 5233
2019
Q1
$1.91M Hold
20,000
﹤0.01% 3670
2018
Q4
$2.48M Buy
+20,000
New +$3.29M ﹤0.01% 3399
2017
Q2
Sell
-60,000
Closed -$4.65M 6849
2017
Q1
$4.65M Buy
+60,000
New +$4.16M ﹤0.01% 2991
2016
Q2
Sell
-34,000
Closed -$1.53M 7127
2016
Q1
$1.53M Buy
+34,000
New +$1.21M ﹤0.01% 3722

Other funds holding INGN

Goldman Sachs's INGN Position: Q2 2026 in Review

Goldman Sachs reduced its Inogen (INGN) stake by 25% in Q2 2026, selling an estimated $956K and leaving 435,585 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #4399.

Goldman Sachs first reported a position in INGN in Q2 2014 and has held it in 45 quarters since. The position peaked at $50.9M in Q3 2018. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • Goldman Sachs held 435,585 shares of Inogen worth $2.81M as of Q2 2026.
  • Goldman Sachs sold 144,515 Inogen shares in Q2 2026, an estimated $956K.
  • Inogen made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4399 holding.
  • Goldman Sachs first reported a position in Inogen in Q2 2014 and has held it in 45 quarters since.
  • Goldman Sachs's Inogen position peaked at $50.9M in Q3 2018.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.